Skip to main content
Clinical Trials/NCT00711113
NCT00711113
Completed
Not Applicable

An Open, Prospective Study to Evaluate Implant Stability, Marginal Bone Adaptation and the Survival Rate of Astra Tech Dental Implant System, Fixture Osseospeed™, in Patients With Tooth Loss in the Posterior Maxilla in an Early Loading Protocol.

Dentsply Sirona Implants and Consumables3 sites in 2 countries47 target enrollmentDecember 2003

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Jaw, Edentulous, Partially
Sponsor
Dentsply Sirona Implants and Consumables
Enrollment
47
Locations
3
Primary Endpoint
Implant Survival Rate
Status
Completed
Last Updated
12 years ago

Overview

Brief Summary

The purpose of the study is to evaluate Astra Tech Dental Implant System, Fixture Osseospeed™, in patients with tooth loss in the posterior maxilla in an early loading protocol. Primary objectives are implant stability, marginal bone adaptation and survival rate.

Registry
clinicaltrials.gov
Start Date
December 2003
End Date
September 2011
Last Updated
12 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Dentsply Sirona Implants and Consumables
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Provision of written informed consent
  • 18 years of age and over
  • Edentulous in the posterior maxilla, Kennedy classes I or II. Last natural tooth, or previously restored implant in function is canine or first bicuspid.
  • Deemed by the investigator as likely to present an initially stabile implant situation suitable for early loading

Exclusion Criteria

  • Untreated caries and/or periodontal disease of residual dentition
  • History of edentulism in the area of implant placement of less than two months
  • Current need for pre-surgical bone or soft tissue augmentation in the planned implant area.
  • History of pre-surgical bone or soft tissue augmentation, within12 months, in the planned implant area.
  • Sinus floor thickness of less than 5 mm, verified by periapical radiographs.
  • Any systemic or local disease or condition that would compromise post-operative healing and/or osseointegration
  • Need for systemic corticosteroids or any other medication that would compromise post-operative healing and/or osseointegration
  • Present alcohol or drug abuse
  • Unable or unwilling to return for follow-up visits for a period of 5 years
  • Current use of smoking tobacco

Outcomes

Primary Outcomes

Implant Survival Rate

Time Frame: At 5 year follow-up

An implant that has failed to osseointegrate, lost its osseointegration or fractured was considered a failure effective from the date of removal. The survival rate for individual implants was analyzed at each visit. Cumulative implant survival rate was calculated using Kaplan-Meier life-table estimation and reported as percentage of survived implants.

Implant Stability

Time Frame: At 1 year follow-up

Implant stability was evaluated using Resonance Frequency Analysis (RFA). The RFA value was automatically translated into an Implant Stability Quotient index (ISQ), which runs from 1 to 100. The ISQ value indicates the level of stability. Low values (\<60) indicate low stability, medium values (60-70) indicate medium stability and high values (\>70) indicate high stability.

Marginal Bone Adaptation

Time Frame: At baseline (loading) and at 5 year follow-up

Marginal bone adaptation was expressed as the distance from the implant reference point to the most coronal bone-to-implant contact on the mesial and distal side of the implant. Bone adaptation in millimeters at follow-up visit were compared to values obtained Baseline (loading). Positive value indicates bone gain and negative value bone loss.

Study Sites (3)

Loading locations...

Similar Trials